文献速递妇科生殖医学

长期外源性睾酮给药对女变男易性症者卵巢形态的影响:经阴道三维超声评估

Effects of long-term exogenous testosterone administration on ovarian morphology, determined by transvaginal (3D) ultrasound in female-to-male transsexuals.
PubMed 文献 · Hum Reprod · 2017-01-01

前瞻性观察性病例对照研究纳入56例女变男易性症者(FtMs)和80例对照,于2014-2015年经阴道三维超声评估卵巢形态。FtMs长期外源性睾酮给药后多囊卵巢形态(PCOM)发生率为32.1%(17/53),对照组为30.7%(23/75),两组无显著差异(P=0.87)。

要点

  • FtMs长期外源性睾酮给药后PCOM发生率为32.1%(17/53),对照组为30.7%(23/75),P=0.87。
  • FtMs的睾酮水平为超生理水平,可能与多囊卵巢综合征(PCOS)女性的睾酮水平不可比。
  • 该首次探索性研究显示长期外源性睾酮给药似乎不诱导经阴道超声诊断的PCOM。

核心结论

  • 成年女性长期外源性睾酮给药似乎不诱导经阴道超声诊断的多囊卵巢形态(PCOM)。

研究设计与样本

  • 前瞻性观察性病例对照研究,在学术机构进行,于2014-2015年开展,纳入56例FtMs和80例对照。
  • FtMs为接受长期睾酮治疗作为跨性别激素治疗一部分并计划行性别重置手术(双侧输卵管卵巢切除术)的成人,术前在麻醉下经阴道三维超声测量卵巢。
  • 对照组为接受相同经阴道超声和分析的普通人群女性。

主要发现

  • FtMs的PCOM发生率为32.1%(17/53),对照组为30.7%(23/75),两组无显著差异(P=0.87),由三维经阴道超声判定。

关键数值与推荐

  • PCOM定义为至少一侧卵巢中直径2-10 mm的卵泡数(AFC)≥12个。
  • 使用专用软件计算三维窦卵泡计数(AFC)和三维卵巢体积。
  • 经阴道超声测量使用三维经阴道探头3-9 MHz(HD11,Philips Ultrasound,Inc.)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • FtMs的睾酮水平为超生理水平,可能与多囊卵巢综合征女性的睾酮水平不可比。
  • 本研究采用了独特且伦理上可接受的探索雄激素对人类卵巢影响的机会。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Does long-term exogenous testosterone administration result in polycystic ovarian morphology (PCOM), determined by (3D) transvaginal ultrasound (TVU) in female-to-male transsexuals (FtMs). SUMMARY ANSWER: Long-term exogenous testosterone administration in FtMs does not result in PCOM determined by (3D) TVU. WHAT IS KNOWN ALREADY: The role of androgens in the pathophysiology of polycystic ovary syndrome (PCOS) is still unclear. From animal studies, intra-ovarian androgens have been suggested to disturb folliculogenesis, through a pro-atretic effect on growing follicles. It remains debatable whether exogenous androgens induce PCOM in humans. In the past histomorphologic studies indicated that androgen administration in FtMs could cause PCO-like changes. However, ultrasound morphology is an established criterion for PCOS, TVU data of ovaries after prolonged androgen exposure are lacking. STUDY DESIGN, SIZE, DURATION: Prospective, observational, case-control study, in an academic setting, performed in 2014-2015, including 56 FtMs and 80 controls. PARTICIPANTS/MATERIALS, SETTING, METHODS: The study population consisted of adult FtMs treated with long-term testosterone, as part of their cross-sex hormone treatment, and scheduled for sex-reassignment surgery (bilateral salpingo-oophorectomy). Prior to the operation, under anaesthetics TVU measurements (3D transvaginal probe 3-9 MHz; HD11, Philips Ultrasound, Inc.) of the ovaries were performed. The control group consisted of females from a general population who underwent the same TVU and analysis. Antral follicle count (AFC) (3D) and ovarian volume (3D) were calculated using specialized software. PCOM was defined as AFC of 12 or more follicles (2-10 mm) in at least one ovary. MAIN RESULTS AND THE ROLE OF CHANCE: Prevalence rates of PCOM were not significantly different in the FtMs compared to controls, determined by (3D) TVU: 32.1% (17/53) versus 30.7% (23/75), P = 0.87. LIMITATIONS, REASONS FOR CAUTION: Testosterone levels in FtMs are supraphysiological, and may not be comparable to the testosterone levels in women with PCOS. However, we applied a unique and ethically acceptable opportunity of exploring the effects of androgens on human ovaries. WIDER IMPLICATIONS OF THE FINDINGS: This first explorative study shows that long-term exogenous testosterone administration in adult women does not seem to induce PCOM determined by TVU. STUDY FUNDING/COMPETING INTEREST(S): None. TRIAL REGISTRATION NUMBER: The trial was registered at the Dutch Trial Register (www.trialregister.nl), registration number NTR4784.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Caanen MR, Schouten NE, Kuijper EAM, et al. Effects of long-term exogenous testosterone administration on ovarian morphology, determined by transvaginal (3D) ultrasound in female-to-male transsexuals. Hum Reprod. 2017. PMID: 28505246. doi:10.1093/humrep/dex098

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。